405 related articles for article (PubMed ID: 18457903)
1. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
2. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
5. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.
Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA
Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134
[TBL] [Abstract][Full Text] [Related]
7. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
9. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
10. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
11. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
Li JY; Englund E; Widner H; Rehncrona S; Björklund A; Lindvall O; Brundin P
Mov Disord; 2010 Jun; 25(8):1091-6. PubMed ID: 20198645
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
16. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
Minguez-Castellanos A; Chamorro CE; Escamilla-Sevilla F; Ortega-Moreno A; Rebollo AC; Gomez-Rio M; Concha A; Munoz DG
Neurology; 2007 Jun; 68(23):2012-8. PubMed ID: 17548551
[TBL] [Abstract][Full Text] [Related]
17. [Update on the pathophysiology of Parkinson' disease].
Duyckaerts C; Sazdovitch V; Seilhean D
Bull Acad Natl Med; 2010 Oct; 194(7):1287-303; discussion 1303-4. PubMed ID: 22043625
[TBL] [Abstract][Full Text] [Related]
18. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
19. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
20. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]